Home > Financial Ratios > SMS PHARMACEUTICALS

SMS PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
SMS PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SMS PHARMACEUTICALS
Please provide your vote to see the results

SMS PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EV/Core EBITDA(x) 12.358.4110.144.337.01

What is the latest EV/Core EBITDA ratio of SMS PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of SMS PHARMACEUTICALS is 12.35 based on Mar2023 Consolidated results.
Year EV/Core EBITDA
Mar202312.35
Mar20228.41
Mar202110.14
Mar20204.33
Mar20197.01

How is EV/Core EBITDA of SMS PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2023 12.35
46.85
Mar2022 8.41
-17.06
Mar2021 10.14
134.18
Mar2020 4.33
-38.23
Mar2019 7.01 -

Other Financial Ratios of SMS PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of SMS PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS ₹1,754.6 Cr -2% 11.9% 148.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹365,167.0 Cr 2.6% -4.7% 54.7% Stock Analytics
CIPLA ₹113,645.0 Cr 4.4% -4.4% 54.7% Stock Analytics
DIVIS LABORATORIES ₹105,890.0 Cr 5.8% 17.7% 24.8% Stock Analytics
DR REDDYS LABORATORIES ₹104,987.0 Cr 5.7% 2.7% 29.3% Stock Analytics
ZYDUS LIFESCIENCES ₹96,950.6 Cr 0.4% -5.4% 82.7% Stock Analytics


SMS PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS

-2%

11.9%

148.4%

SENSEX

1.4%

2.5%

24.3%


You may also like the below Video Courses